000154764 001__ 154764
000154764 005__ 20240229123111.0
000154764 0247_ $$2doi$$a10.1002/ijc.33043
000154764 0247_ $$2pmid$$apmid:32391587
000154764 0247_ $$2ISSN$$a0020-7136
000154764 0247_ $$2ISSN$$a1097-0215
000154764 0247_ $$2altmetric$$aaltmetric:81846908
000154764 037__ $$aDKFZ-2020-01011
000154764 041__ $$aeng
000154764 082__ $$a610
000154764 1001_ $$00000-0001-7813-6272$$aGibbs, David Corley$$b0
000154764 245__ $$aAssociation of pre-diagnostic vitamin D status with mortality among colorectal cancer patients differs by common, inherited vitamin D-binding protein isoforms.
000154764 260__ $$aBognor Regis$$bWiley-Liss$$c2020
000154764 3367_ $$2DRIVER$$aarticle
000154764 3367_ $$2DataCite$$aOutput Types/Journal article
000154764 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1602766095_10922
000154764 3367_ $$2BibTeX$$aARTICLE
000154764 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000154764 3367_ $$00$$2EndNote$$aJournal Article
000154764 500__ $$a2020 Nov 15;147(10):2725-2734
000154764 520__ $$aLower pre-diagnostic circulating 25-hydroxyvitamin D (25[OH]D)-considered the best marker of total vitamin D exposure-is associated with higher mortality risk among colorectal cancer (CRC) patients. However, it is unknown whether this association differs by the vitamin D-binding protein (GC) isoform Gc2 (encoded by GC rs4588*C>A, Thr436Lys), which may substantially affect vitamin D metabolism and modify associations of 25(OH)D with colorectal neoplasm risk. Pre-diagnostic 25(OH)D-mortality associations according to Gc2 isoform were estimated using multivariable Cox proportional hazards regression among 1,281 CRC cases (635 deaths, 483 from CRC) from two large prospective cohorts conducted in the United States (Cancer Prevention Study-II) and Europe (European Prospective Investigation into Cancer and Nutrition). 25(OH)D measurements were calibrated to a single assay, season standardized, and categorized using Institute of Medicine recommendations (deficient [<30], insufficient [30 - <50], sufficient [≥50 nmol/L]). In the pooled analysis, multivariable-adjusted hazard ratios (HRs) for CRC-specific mortality associated with deficient relative to sufficient 25(OH)D concentrations were 2.24 (95% CI 1.44-3.49) among cases with the Gc2 isoform, and 0.94 (95% CI 0.68-1.22) among cases without Gc2 (Pinteraction = 0.0002). The corresponding HRs for all-cause mortality were 1.80 (95% CI 1.24-2.60) among those with Gc2, and 1.12 (95% CI 0.84-1.51) among those without Gc2 (Pinteraction = 0.004). Our findings suggest that the association of pre-diagnostic vitamin D status with mortality among CRC patients may differ by functional GC isoforms, and patients who inherit the Gc2 isoform (GC rs4588*A) may particularly benefit from higher circulating 25(OH)D for improved CRC prognosis.
000154764 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000154764 588__ $$aDataset connected to CrossRef, PubMed,
000154764 7001_ $$aBostick, Roberd M$$b1
000154764 7001_ $$aMcCullough, Marjorie$$b2
000154764 7001_ $$aUm, Caroline$$b3
000154764 7001_ $$aFlanders, Dana$$b4
000154764 7001_ $$aJenab, Mazda$$b5
000154764 7001_ $$00000-0003-2237-0128$$aWeiderpass, Elisabete$$b6
000154764 7001_ $$aGylling, Björn$$b7
000154764 7001_ $$aGram, Inger T$$b8
000154764 7001_ $$aHeath, Alicia K$$b9
000154764 7001_ $$aColorado-Yohar, Sandra$$b10
000154764 7001_ $$aDahm, Christina C$$b11
000154764 7001_ $$aBueno-de-Mesquita, Bas$$b12
000154764 7001_ $$aPerez-Cornago, Aurora$$b13
000154764 7001_ $$aTrichopoulou, Antonia$$b14
000154764 7001_ $$aTumino, Rosario$$b15
000154764 7001_ $$0P:(DE-He78)0907a10ba1dc8f53f04907f54f6fdcfe$$aKühn, Tilman$$b16$$udkfz
000154764 7001_ $$00000-0002-7805-9913$$aFedirko, Veronika$$b17
000154764 773__ $$0PERI:(DE-600)1474822-8$$a10.1002/ijc.33043$$gp. ijc.33043$$n10$$p2725-2734$$tInternational journal of cancer$$v147$$x1097-0215$$y2020
000154764 909CO $$ooai:inrepo02.dkfz.de:154764$$pVDB
000154764 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)0907a10ba1dc8f53f04907f54f6fdcfe$$aDeutsches Krebsforschungszentrum$$b16$$kDKFZ
000154764 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000154764 9141_ $$y2020
000154764 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000154764 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000154764 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000154764 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000154764 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bINT J CANCER : 2017
000154764 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000154764 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000154764 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000154764 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000154764 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000154764 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000154764 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bINT J CANCER : 2017
000154764 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000154764 980__ $$ajournal
000154764 980__ $$aVDB
000154764 980__ $$aI:(DE-He78)C020-20160331
000154764 980__ $$aUNRESTRICTED